114 related articles for article (PubMed ID: 33580878)
1. Sevoflurane-induced hyperglycemia is attenuated by salsalate in obese insulin-resistant mice.
Desjardins EM; Smith BK; Steinberg GR; Brown RE
Can J Anaesth; 2021 Jul; 68(7):972-979. PubMed ID: 33580878
[TBL] [Abstract][Full Text] [Related]
2. Sevoflurane Impairs Insulin Secretion and Tissue-Specific Glucose Uptake In Vivo.
Høyer KF; Nielsen TS; Risis S; Treebak JT; Jessen N
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):732-738. PubMed ID: 29956485
[TBL] [Abstract][Full Text] [Related]
3. Salsalate Activates Skeletal Muscle Thermogenesis and Protects Mice from High-Fat Diet Induced Metabolic Dysfunction.
Nie L; Yuan XL; Jiang KT; Jiang YH; Yuan J; Luo L; Cui SW; Sun C
EBioMedicine; 2017 Sep; 23():136-145. PubMed ID: 28801239
[TBL] [Abstract][Full Text] [Related]
4. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.
Goldfine AB; Silver R; Aldhahi W; Cai D; Tatro E; Lee J; Shoelson SE
Clin Transl Sci; 2008 May; 1(1):36-43. PubMed ID: 19337387
[TBL] [Abstract][Full Text] [Related]
5. The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats.
Kitamura T; Ogawa M; Kawamura G; Sato K; Yamada Y
Anesth Analg; 2009 Nov; 109(5):1479-85. PubMed ID: 19843785
[TBL] [Abstract][Full Text] [Related]
6. Salsalate has no effect on insulin secretion but decreases insulin clearance: a randomized, placebo-controlled trial in subjects without diabetes.
Penesova A; Koska J; Ortega E; Bunt JC; Bogardus C; de Courten B
Diabetes Obes Metab; 2015 Jun; 17(6):608-612. PubMed ID: 25683256
[TBL] [Abstract][Full Text] [Related]
7. Potential role of salicylates in type 2 diabetes.
Rumore MM; Kim KS
Ann Pharmacother; 2010; 44(7-8):1207-21. PubMed ID: 20516365
[TBL] [Abstract][Full Text] [Related]
8. Salsalate treatment improves glycemia without altering adipose tissue in nondiabetic obese hispanics.
Alderete TL; Sattler FR; Richey JM; Allayee H; Mittelman SD; Sheng X; Tucci J; Gyllenhammer LE; Grant EG; Goran MI
Obesity (Silver Spring); 2015 Mar; 23(3):543-51. PubMed ID: 25644856
[TBL] [Abstract][Full Text] [Related]
9. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity.
Mizuno TM; Bergen H; Funabashi T; Kleopoulos SP; Zhong YG; Bauman WA; Mobbs CV
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3434-8. PubMed ID: 8622953
[TBL] [Abstract][Full Text] [Related]
10. Salsalate improves glycemia and inflammatory parameters in obese young adults.
Fleischman A; Shoelson SE; Bernier R; Goldfine AB
Diabetes Care; 2008 Feb; 31(2):289-94. PubMed ID: 17959861
[TBL] [Abstract][Full Text] [Related]
11. Salsalate activates brown adipose tissue in mice.
van Dam AD; Nahon KJ; Kooijman S; van den Berg SM; Kanhai AA; Kikuchi T; Heemskerk MM; van Harmelen V; Lombès M; van den Hoek AM; de Winther MP; Lutgens E; Guigas B; Rensen PC; Boon MR
Diabetes; 2015 May; 64(5):1544-54. PubMed ID: 25475439
[TBL] [Abstract][Full Text] [Related]
12. The involvement of adenosine triphosphate-sensitive potassium channels in the different effects of sevoflurane and propofol on glucose metabolism in fed rats.
Kitamura T; Sato K; Kawamura G; Yamada Y
Anesth Analg; 2012 Jan; 114(1):110-6. PubMed ID: 22127813
[TBL] [Abstract][Full Text] [Related]
13. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Liang Y; Cincotta AH
Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
[TBL] [Abstract][Full Text] [Related]
14. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice.
Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH
Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568
[TBL] [Abstract][Full Text] [Related]
15. Obesity exacerbates the acute metabolic side effects of olanzapine.
Townsend LK; Peppler WT; Bush ND; Wright DC
Psychoneuroendocrinology; 2018 Feb; 88():121-128. PubMed ID: 29241148
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions.
Meex RC; Phielix E; Moonen-Kornips E; Schrauwen P; Hesselink MK
J Clin Endocrinol Metab; 2011 May; 96(5):1415-23. PubMed ID: 21289240
[TBL] [Abstract][Full Text] [Related]
17. The actions of dichloroacetic acid on blood glucose, liver glycogen and fatty acid synthesis in obese-hyperglycaemic (ob/ob) and lean mice.
Enser M; Whittington FM
Horm Metab Res; 1983 May; 15(5):225-9. PubMed ID: 6347856
[TBL] [Abstract][Full Text] [Related]
18. Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mouse.
Kuhn CM; Cochrane C; Feinglos MN; Surwit RS
Pharmacol Biochem Behav; 1987 Mar; 26(3):491-5. PubMed ID: 3554269
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway.
Gabriely I; Yang XM; Cases JA; Ma XH; Rossetti L; Barzilai N
Atherosclerosis; 2002 Jan; 160(1):115-22. PubMed ID: 11755928
[TBL] [Abstract][Full Text] [Related]
20. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
